EC Approves NVS Kisqali for a Broad Population in Early Breast Cancer
| VCIGX Fund | USD 13.22 0.03 0.23% |
Slightly above 54% of Valic Company's investor base is interested to short. The analysis of overall sentiment of trading Valic Company I mutual fund suggests that many investors are impartial at this time. Valic Company's investing sentiment can be driven by a variety of factors including economic data, Valic Company's earnings reports, geopolitical events, and overall market trends.
Valic |
Novartis wins EC approval for Kisqali in a broad population of patients with HRHER2- early breast cancer at high risk of recurrence.
Read at finance.yahoo.com
 |
Valic Company Fundamental Analysis
We analyze Valic Company's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valic Company using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valic Company based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Valic Company is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Valic Company I Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Valic Company mutual fund to make a market-neutral strategy. Peer analysis of Valic Company could also be used in its relative valuation, which is a method of valuing Valic Company by comparing valuation metrics with similar companies.
Peers
Valic Company Related Equities
| CFAIX | Calvert Conservative | 0.33 | ||||
| HUDEX | Huber Capital | 0.24 | ||||
| MDBLX | Massmutual Premier | 0.24 | ||||
| MDVSX | Massmutual Select | 0.18 | ||||
| EVFCX | Evaluator Conservative | 0.10 | ||||
| QDARX | Aqr Diversified | 0.08 |
Other Information on Investing in Valic Mutual Fund
Valic Company financial ratios help investors to determine whether Valic Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valic with respect to the benefits of owning Valic Company security.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |